what is durvalumab’s future as a treatment option in lung cancer?
Published 7 years ago • 300 plays • Length 3:39Download video MP4
Download video MP3
Similar videos
-
2:15
the impact of durvalumab for resectable non-small cell lung cancer
-
2:03
tremelimumab and durvalumab therapy in lung cancer
-
1:24
durvalumab: the new standard of care for nsclc?
-
6:48
durvalumab improves pfs in stage iii lung cancer
-
11:11
extending durvalumab maintenance to special populations
-
1:13
phase ii study of durvalumab for patients with nsclc
-
3:39
results from the pacific study: durvalumab with chemoradiation for the treatment of nsclc
-
15:25
targeted therapies: the future of non-small cell lung cancer (nsclc) treatment?
-
2:53
delta-radiomics predicting response and overall-survival in advanced nsclc treated with durvalumab
-
3:48
poseidon: durvalumab /- tremelimumab chemo in 1l mnsclc
-
1:24
is immunotherapy the future for lung cancer?
-
2:21
current treatment options for nsclc without driver mutations
-
4:37
durvalumab: a new option for stage iii nsclc patients? | davey daniel
-
2:10
poseidon: 4 year follow up of durvalumab and tremelimumab in nsclc
-
3:25
pacific 6: durvalumab after scrt in patients with nsclc
-
1:18
a study of chemotherapy with durvalumab and tremelimumab in nsclc
-
6:06
stage iii nsclc: when to start durvalumab
-
1:25
neoadjuvant therapy is taking off in lung cancer
-
2:53
hudson: durvalumab combination therapies to overcome pd-l1 blockade resistance in advanced nsclc